Gyorgy Vas, Principal Scientist, Johnson & Johnson, Product and Process Scientific Solutions, Analytical Development, has a M Sc Analytical Chemistry and a Ph. D. in Mass Spectrometry. He has published 16 research papers, which have been cited more than 750 times. Gyorgy has worked for Johnson & Johnson for 6 years and is an expert in trace level analytical method development and method validation. He was also the recipient of Johnson & Johnson Outstanding Analytical Scientist Award
Enter your contact details and the nature of your enquiry below:
*Mandatory
Carsten Worsøe is a research scientist in an analytical development department at Novo Nordisk. In his 10 years at Novo Nordisk, his main responsibility has been to develop analytical methods for L&E test procedures of new packaging/container closure systems under development.
Kumudini is an Advisor/Team Leader for the Generic Drugs Quality Division II for Parenteral and Ophthalmic products as Health Canada. She chairs the Technical Discussion Group mandates to address issues concerning container closure systems used to package pharmaceutical dosage forms. In 2009, she drafted a guideline titled Selection and Qualification of a Plastic Container Closure System for Pharmaceutical Product to assist the drug review process in the Bureau of Pharmaceutical Sciences, Health Canada, and the pharmaceutical industry in Canada, which is currently under review by the Policy Bureau of the Therapeutic Products Directorate of Health Canada.
Dr. Dima Al-hadithi obtained her Pharmacy degree from Bath University and completed her PhD at the School of Pharmacy, University of London. In 2005, following a stint as a Senior Formulation Scientist at Phoqus Pharmaceuticals where she specialised in dry powder electrostatic deposition coating technology of solid dosage forms, including multi-layer modified release tablets, Dima joined the Medicines and Healthcare products Regulatory Agency based in London. Her current role is as a Senior Pharmaceutical Assessor and Deputy Manager in the Product Lifecycle Assessment Team responsible for evaluating UK and European Marketing Authorisation Applications and post-approval variations for products indicated for the diagnosis and treatment of gastrointestinal disease, nutrition and diseases of the blood as well as over-the-counter products.
Dr. Norwood is a Distinguished Research Fellow in Analytical Development for Boehringer Ingelheim Pharmaceuticals, Inc., and has held senior industry positions at Magellan Laboratories and the Glaxo Research Institute. He chaired the PQRI working group on Leachables and Extractables in Orally Inhaled and Nasal Drug Products, and is currently a member of the PQRI working group for Parenteral and Ophthalmic Drug Products.